{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:16:36Z","timestamp":1778127396945,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T00:00:00Z","timestamp":1744502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI118774"],"award-info":[{"award-number":["R01AI118774"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-19-1-0760"],"award-info":[{"award-number":["W81XWH-19-1-0760"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bbi.2025.04.017","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T10:44:50Z","timestamp":1744713890000},"page":"352-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Sustained NPSLE-like phenotype in the absence of systemic lupus-like disease in TLR7-deficient B6.Nba2 mice"],"prefix":"10.1016","volume":"128","author":[{"given":"Audrey","family":"Kwun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James K.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Shelestak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayla M.","family":"Merritt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selena S.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrielle","family":"Mey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"DeSilva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8566-4647","authenticated-orcid":false,"given":"Trine N.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2025.04.017_b0010","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","author":"American College of Rheumatology","year":"1999","journal-title":"Arthrit. Rheum."},{"key":"10.1016\/j.bbi.2025.04.017_b0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-2094-9-23","article-title":"TNF-\u03b1 protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation","volume":"9","author":"Belarbi","year":"2012","journal-title":"J. Neuroinflam."},{"key":"10.1016\/j.bbi.2025.04.017_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.970906","article-title":"IL-10 revisited in systemic lupus erythematosus","volume":"13","author":"Biswas","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2025.04.017_b0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.molmed.2012.01.008","article-title":"The DWEYS peptide in systemic lupus erythematosus","volume":"18","author":"Bosch","year":"2012","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbi.2025.04.017_b0035","doi-asserted-by":"crossref","unstructured":"Browne, K., Zhang, E., Sullivan, J.K., Evonuk, K.S., DeSilva, T.M., Jorgensen, T.N., 2021. Lupus-prone B6.Nba2 male and female mice display anti-DWEYS reactivity and a neuropsychiatric phenotype. Brain Behav. and Immun. https:\/\/doi.org\/10.1016\/j.bbi.2021.02.010.","DOI":"10.1016\/j.bbi.2021.02.010"},{"key":"10.1016\/j.bbi.2025.04.017_b0040","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1177\/09612033221127561","article-title":"Ablation of SigH+ pDCs in B6.Nba2 mice prevents lupus-like disease development only if started before disease is fully established","volume":"31","author":"Campbell","year":"2022","journal-title":"Lupus"},{"key":"10.1016\/j.bbi.2025.04.017_b0045","article-title":"Defining the role of Interleukin-6 for the development of perioperative neurocognitive disorders: Evidence from clinical and preclinical studies","volume":"14","author":"Chang","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbi.2025.04.017_b0055","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3389\/fimmu.2019.02017","article-title":"Limited Effect of Indolamine 2,3-Dioxygenase Expression and Enzymatic Activity on Lupus-Like Disease in B6.Nba2 Mice","volume":"10","author":"Davison","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2025.04.017_b0060","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nm1101-1189","article-title":"A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus","volume":"7","author":"Degiorgio","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2025.04.017_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2017.01.018","article-title":"Differential reactive oxygen species production of neutrophils and their oxidative damage in patients with active and inactive systemic lupus erythematosus","volume":"184","author":"Elloumi","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.bbi.2025.04.017_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1111769","article-title":"The conundrum of neuropsychiatric systemic lupus erythematosus: Current and novel approaches to diagnosis","volume":"14","author":"Emerson","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbi.2025.04.017_b0075","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.3390\/jcm10245837","article-title":"The complex role of C-reactive protein in systemic lupus erythematosus","volume":"10","author":"Enocsson","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbi.2025.04.017_b0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbi.2025.04.017_b0085","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1084\/jem.20122798","article-title":"Overexpression of TLR7 promotes cell-intrinsic expansion and autoantibody production by transitional T1 B cells","volume":"210","author":"Giltiay","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2025.04.017_b0090","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrrheum.2014.15","article-title":"Diagnosis and management of neuropsychiatric SLE","volume":"10","author":"Hanly","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bbi.2025.04.017_b0095","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nature03464","article-title":"IRF-7 is the master regulator of type-I interferon-dependent immune responses","volume":"434","author":"Honda","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2025.04.017_b0100","doi-asserted-by":"crossref","first-page":"775","DOI":"10.4049\/jimmunol.0901322","article-title":"Development of murine lupus involves the combined genetic contribution of the SLAM and Fc\u03b3R intervals within the Nba2 autoimmune susceptibility locus","volume":"184","author":"J\u00f8rgensen","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2025.04.017_b0105","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/sj.gene.6364430","article-title":"Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 \u00d7 NZW)F1 mice","volume":"8","author":"J\u00f8rgensen","year":"2007","journal-title":"Genes Immun."},{"key":"10.1016\/j.bbi.2025.04.017_b0110","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.3390\/ijms22094837","article-title":"Serotonin\u2014its synthesis and roles in the healthy and the critically Ill","volume":"22","author":"Kanova","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2025.04.017_b0115","doi-asserted-by":"crossref","first-page":"11714","DOI":"10.3390\/ijms222111714","article-title":"Tryptophan: A Unique Role in the Critically Ill","volume":"22","author":"Kanova","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2025.04.017_b0120","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.addr.2007.12.004","article-title":"TLR9 as a key receptor for the recognition of DNA","volume":"60","author":"Kumagai","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbi.2025.04.017_b0125","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.4049\/jimmunol.0803219","article-title":"Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus1","volume":"183","author":"Lartigue","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2025.04.017_b0130","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/1535370214525299","article-title":"Interactions of surface-expressed TLR-4 and endosomal TLR-9 accelerate lupus progression in anti-dsDNA antibody transgenic mice","volume":"239","author":"Lee","year":"2014","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.bbi.2025.04.017_b0135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrrheum.2018.38","article-title":"The non-haemostatic role of platelets in systemic lupus erythematosus","volume":"14","author":"Linge","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bbi.2025.04.017_b0140","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10787-019-00587-4","article-title":"Limited preventive effect of prednisone on neuropsychiatric symptoms in murine systemic lupus erythematosus","volume":"27","author":"Lu","year":"2019","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bbi.2025.04.017_b0145","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fimmu.2020.00230","article-title":"A novel microglia-specific transcriptional signature correlates with behavioral deficits in neuropsychiatric lupus","volume":"11","author":"Makinde","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2025.04.017_b0150","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/art.1780241207","article-title":"Decreased platelet serotonin levels in systemic lupus erythematosus","volume":"24","author":"Meyerhoff","year":"1981","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbi.2025.04.017_b0155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.molimm.2022.04.003","article-title":"IL-6 regulates induction of C-reactive protein gene expression by activating STAT3 isoforms","volume":"146","author":"Ngwa","year":"2022","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbi.2025.04.017_b0160","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/09612033231221651","article-title":"Impaired serotonin synthesis in hippocampus of murine lupus represents an early neuropsychiatric event","volume":"33","author":"Nikolopoulos","year":"2024","journal-title":"Lupus"},{"key":"10.1016\/j.bbi.2025.04.017_b0165","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12865-020-0335-7","article-title":"Inducible nitric oxide synthase and systemic lupus erythematosus: a systematic review and meta-analysis","volume":"21","author":"Pan","year":"2020","journal-title":"BMC Immunol."},{"issue":"6","key":"10.1016\/j.bbi.2025.04.017_b0170","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3390\/molecules29061411","article-title":"Nitric Oxide (NO) synthase inhibitors: potential candidates for the treatment of anxiety disorders?","volume":"29","author":"Pitsikas","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bbi.2025.04.017_b0175","article-title":"Immune receptor toll-like receptor 4 contributes to stress-induced affective responses in a sex-specific manner","volume":"14","author":"Quave","year":"2021","journal-title":"Brain Behav. Immun. - Health"},{"key":"10.1016\/j.bbi.2025.04.017_b0180","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12974-024-03085-9","article-title":"Constitutive knockout of interleukin-6 ameliorates memory deficits and entorhinal astrocytosis in the MRL\/lpr mouse model of neuropsychiatric lupus","volume":"21","author":"Reynolds","year":"2024","journal-title":"J. Neuroinflam."},{"key":"10.1016\/j.bbi.2025.04.017_b0185","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jaut.2009.11.001","article-title":"Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice","volume":"34","author":"Santiago-Raber","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbi.2025.04.017_b0190","first-page":"162","article-title":"Advanced and conventional magnetic resonance imaging in neuropsychiatric lupus","volume":"4","author":"Sarbu","year":"2015","journal-title":"F1000Res"},{"key":"10.1016\/j.bbi.2025.04.017_b0195","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41584-018-0156-8","article-title":"Neuropsychiatric lupus: new mechanistic insights and future treatment directions","volume":"15","author":"Schwartz","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bbi.2025.04.017_b0200","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav9019","article-title":"Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement\u2014a new target for lupus treatment","volume":"5","author":"Smith","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbi.2025.04.017_b0205","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.4049\/jimmunol.1401720","article-title":"B cell-intrinsic TLR7 signaling is essential for the development of spontaneous germinal centers","volume":"193","author":"Soni","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2025.04.017_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14397595.2020.1812201","article-title":"Anifrolumab, a monoclonal antibody to the type I interferon receptor subunit 1, for the treatment of systemic lupus erythematosus: an overview from clinical trials","volume":"31","author":"Tanaka","year":"2021","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.bbi.2025.04.017_b0215","doi-asserted-by":"crossref","first-page":"14694","DOI":"10.1073\/pnas.2003034117","article-title":"DNA-based fluorescent probes of NOS2 activity in live brains","volume":"117","author":"Veetil","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbi.2025.04.017_b0220","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fmed.2018.00138","article-title":"Definition of NPSLE: does the ACR nomenclature still hold?","volume":"5","author":"Vivaldo","year":"2018","journal-title":"Front Med. (Lausanne)"},{"key":"10.1016\/j.bbi.2025.04.017_b0225","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.3390\/jcm11174955","article-title":"Progress in the pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus","volume":"11","author":"Wang","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbi.2025.04.017_b0230","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bbi.2013.03.004","article-title":"Blocking toll-like receptor 2 and 4 signaling during a stressor prevents stress-induced priming of neuroinflammatory responses to a subsequent immune challenge","volume":"32","author":"Weber","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2025.04.017_b0235","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12974-016-0537-3","article-title":"B cell and\/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus","volume":"13","author":"Wen","year":"2016","journal-title":"J. Neuroinflam."},{"key":"10.1016\/j.bbi.2025.04.017_b0240","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaut.2015.03.005","article-title":"TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL\/lpr mice","volume":"60","author":"Wen","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbi.2025.04.017_b0245","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/aps.2015.91","article-title":"Toll-like receptors: potential targets for lupus treatment","volume":"36","author":"Wu","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbi.2025.04.017_b0250","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/biom11070928","article-title":"Clinical and immunological biomarkers for systemic lupus erythematosus","volume":"11","author":"Yu","year":"2021","journal-title":"Biomolecules"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125001515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125001515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:46:49Z","timestamp":1778125609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159125001515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":47,"alternative-id":["S0889159125001515"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2025.04.017","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained NPSLE-like phenotype in the absence of systemic lupus-like disease in TLR7-deficient B6.Nba2 mice","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2025.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}